ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SBTX Skinbiotherapeutics Plc

9.25
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherapeutics Plc LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 9.25 9.00 9.50 9.25 9.25 9.25 126,038 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 132k -2.84M -0.0163 -5.67 16.1M
Skinbiotherapeutics Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker SBTX. The last closing price for Skinbiotherapeutics was 9.25p. Over the last year, Skinbiotherapeutics shares have traded in a share price range of 7.25p to 29.50p.

Skinbiotherapeutics currently has 174,004,323 shares in issue. The market capitalisation of Skinbiotherapeutics is £16.10 million. Skinbiotherapeutics has a price to earnings ratio (PE ratio) of -5.67.

Skinbiotherapeutics Share Discussion Threads

Showing 1426 to 1447 of 23475 messages
Chat Pages: Latest  63  62  61  60  59  58  57  56  55  54  53  52  Older
DateSubjectAuthorDiscuss
14/3/2018
11:49
3 month high.
parob
14/3/2018
11:11
I see someone just completed a quick day trade for £440 profit. Good luck to them but if they held for a few months more then they would probably have made a great deal in excess of that.
rafboy
14/3/2018
11:08
People taking positions following that excellent presentation by the CEO.
rafboy
14/3/2018
10:36
No overhang either watching level 2.
Virtually every buy has moved an MM all morning!

God knows what would happen if we had any volume!

shrewdmole
14/3/2018
10:27
Agreed and she is very confident and knowledgeable. Great time to buy as the share price will only increase as we near the human trials.
rafboy
14/3/2018
10:22
The fact that companies are approaching Cath is HUGE for me. With her already existing contacts in the industry, once (we hope) the trials prove positive, things will move very fast IMO.
loungeact
14/3/2018
09:29
Nice bit of buying so far today.
rafboy
13/3/2018
18:01
Excellent presentation from Cath.
onedayrodders
12/3/2018
19:54
One of the important aspects we need to remember about SBTX and it's continued relationship UoM, is the fact many of the worlds dermatology companies are already associated in some way to SBTX, via Cath. J&J probably the most well known. Also, as Cath mentioned, some of these companies have approached Cath for advice and wanted to know why she had not been more proactive in contacting them with her work. This should demonstrated the high respect they have for Cath, but also her work. In most cases, this is the hard work in opening commercial doors, these doors have already been opened, so SBTX need to do now, is show the IP works in human trials and let the budding begin.

The other aspect she spoke about was the fact cosmetics cannot make any health claims, yet household names are making $bls on the back on the perception they can do x, but they clearly do not. SBTX will clearly have a clear advantage - a good example of this was the boots product.

She dropped a clanger with the OPTI market value at £100m.....not quite there yet. I guess she must be thinking TW was right on the money with his valuation. ;)

elrico
12/3/2018
19:20
This Thursday she is doing another presentation, this time in Paris. She has been doing a load of promotions since Feb 20th including one in Amsterdam. This will all equate to more partnering with Bigger Corporates to do the marketing later this year imo.

Company CEO Cath O’Neill to showcase SkinBioTherapeutics plc at Pharmabiotics2018 in Paris on March 15th. @Pharmabiotics #SBTX



eXCELLENT POST WELL DONE...

elrico12 Mar '18 - 15:48 - 1427 of 1428

Latest presentation from CEO Cath O'Neill at Shares Investor Evening in Edinburgh is now available @SHARESmag #SBTX

bobalot
12/3/2018
15:53
Very good presentation. Confident that things will go well for SBTX. It seems our CEO has some excellent contacts and is very aware of the company’s worth following the human trials.
rafboy
12/3/2018
15:48
Latest presentation from CEO Cath O'Neill at Shares Investor Evening in Edinburgh is now available @SHARESmag #SBTX
elrico
12/3/2018
14:26
We both know i'm not filtered :D
loungeact
12/3/2018
14:21
loungeact12 Mar '18 - 13:48 - 1423 of 1423 (Filtered) more of the same rubbish imo.


loungeact12 Mar '18 - 14:26 - 1425 of 1425 (Filtered) A COMPULSIVE REPETITIVE DISORDER imo..lol

bobalot
12/3/2018
13:48
You've been through this issue countless times with OPTI holders. OPTI holders will be issued shares as a divi. I know this is difficult for you to accept because you sold all your OPTI shares to invest into SBTX. So, it doesn't really matter what anyone says, you will have your agenda. Your agenda is also clear from your posts on the OPTI BB, where you now bash the company and CEO in an attempt to discredit, hoping investors put their money into SBTX, again to serve your agenda. Also obvious from your ramping here.

I think OPTI will reach £1 before much happens here, and I know that must be tough for you somewhat, sitting on a loss right now, but I think SBTX will have it's day. In turn making even more money for OPTI holders - hurts a little doesn't it? :)

It's really cute that you can't bring yourself to actually filter me, but you really should and show some integrity for once. Otherwise, you're coming off as really sad.

Looking forward to the trials later this year when this thing really gets moving.

loungeact
12/3/2018
12:55
Dear bob, there has been an rns about the sbtx divi and from a credible source. What do you think a 'dividend in specie.' Sbtx is the only company Opti have another holding of a quoted company.

OptiBiotix is pleased to announce that, following shareholder approval which was granted on 25 January 2018, the High Court of Justice made an order confirming the Capital Reduction on 27 February 2018.

Following the registration of the Court order confirming the Capital Reduction by the Registrar of Companies in England and Wales, the Capital Reduction became effective 27 February 2018.

Stephen O'Hara, CEO of OptiBiotix, commented: "I am pleased to report that both shareholders and the Courts have confirmed the capital reduction. This allows OptiBiotix to make future dividend or 'dividend in specie' distributions to the Company's shareholders should it be appropriate to do so. This is part of OptiBiotix's strategy of building value across its divisions and where possible releasing value back to shareholders."

ps i'm going to give your post 1404 some coins because i think your lack of knowledge deserves flagging for all visitors because you are dangerous, or would be if people took you seriously.

incanus
12/3/2018
12:34
It is well worth new investors to read articles from reliable sources:


SkinBioTherapeutics 'making very good headway' in development of three key programmes

Dr Cath O'Neill, chief executive of SkinBioTherapeutics PLC (LON:SBTX), caught up with Proactive's Andrew Scott following the release of the skin-health specialist's interim results.

She says they remain on track with the development of their three flagship programmes - in particular the upcoming first human study for the cosmetic application of the compound which is planned for the third quarter of this year.

www.proactiveinvestors.co.uk/companies/stocktube/8805/skinbiotherapeutics-making-very-good-headway-in-development-of-three-key-programmes-8805.html

bobalot
12/3/2018
12:21
the follow feed doesn't filter people and that really is a pity because you repeat yourself constantly...a real troll imo.
bobalot
12/3/2018
12:14
I see you've taken me off filter or I was just never filtered? :) Lack of integrity I see.

You've been through this issue countless times with OPTI holders. OPTI holders will be issued shares as a divi. I know this is difficult for you to accept because you sold all your OPTI shares to invest into SBTX. So, it doesn't really matter what anyone says, you will have your agenda. Your agenda is also clear from your posts on the OPTI BB, where you now bash the company and CEO in an attempt to discredit, hoping investors put their money into SBTX, again to serve your agenda. Also obvious from your ramping here.

I think OPTI will reach £1 before much happens here, and I know that must be tough for you somewhat, sitting on a loss right now, but I think SBTX will have it's day. In turn making even more money for OPTI holders - hurts a little doesn't it? :)

It's really cute that you can't bring yourself to actually filter me, but you really should and show some integrity for once. Otherwise, you're coming off as really sad.

Looking forward to the trials later this year when this thing really gets moving.

loungeact
12/3/2018
12:00
There has never been an RNS about SBTX shares issued as a divi from OPTI...until that happens you are spouting gossip or fake claims.
bobalot
12/3/2018
11:56
Some good ramping there Bob.

Personally don't think much will happen until the trials, but I hope i'm wrong. The sooner the better for OPTI holders who are getting free SBTX shares.

loungeact
12/3/2018
11:50
It is highly likely that newsflow will start fairly soon about more patent approvals for China, USA etc after getting a patent approval from Australia recently.

Adding yet more value to the share price

bobalot
Chat Pages: Latest  63  62  61  60  59  58  57  56  55  54  53  52  Older

Your Recent History

Delayed Upgrade Clock